Literature DB >> 8815000

Effect of antisense inhibition of Urokinase receptor on malignancy.

L Ossowski1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815000     DOI: 10.1007/978-3-642-80071-9_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  5 in total

Review 1.  Angiogenesis in cancer: Anti-VEGF escape mechanisms.

Authors:  Gerald W Prager; Marina Poettler; Matthias Unseld; Christoph C Zielinski
Journal:  Transl Lung Cancer Res       Date:  2012-03

2.  uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.

Authors:  Hari Raghu; Arun Kumar Nalla; Christopher S Gondi; Meena Gujrati; Dzunh H Dinh; Jasti S Rao
Journal:  Mol Oncol       Date:  2011-11-30       Impact factor: 6.603

3.  Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.

Authors:  P Carmeliet; L Moons; M Dewerchin; S Rosenberg; J M Herbert; F Lupu; D Collen
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

4.  Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.

Authors:  J S Rao; M Gujrati; C Chetty
Journal:  Oncogenesis       Date:  2013-06-24       Impact factor: 7.485

Review 5.  Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.

Authors:  Maria Teresa Masucci; Michele Minopoli; Gioconda Di Carluccio; Maria Letizia Motti; Maria Vincenza Carriero
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.